Merck And Wondfo Launch A Pilot Project

Merck and Wondfo Biotech Launch a Pilot Project to Improve the Access to Diagnosis and Treatment of Thyroid Diseases at the Primary Care Level

February 25, 2022, Guangzhou, China – Merck, a global leading science and technology company signed a cooperation agreement with Guangzhou Wondfo Biotech Co., Ltd. (Wondfo Biotech), whereby both will leverage their respective strengths in thyroid disease treatment and in vitro diagnosis to increase the accessibility of thyroid function testing in community-level hospitals, and to help improve the capability of those hospitals in thyroid disease diagnosis and treatment.
Many customers, who have cooperated with Wondfo for years, specially visited Wondfo’s booth for the demonstration of Accre System. We are excited to have new cooperation in Accre system, and we are honored to have customers’ appreciation.